Suchergebnisse
Suchergebnisse:
Merck Switzerland is a hub for biotech medicines production and R&D, with sites in Aubonne, Corsier-sur-Vevey, EPFL and Zug. The Corsier-sur-Vevey site is a global center of expertise for drug substance production and process development for Merck's biotech medicines.
27. Jan. 2020 · Merck, a leading science and technology company, announced a new biotech development center in Switzerland to bridge research and manufacturing for clinical studies. The facility, expected to be operational by the end of 2022, will accelerate the availability of new biotech medicines for patients.
- Merck Biotech Development Facility Location
- Details of Merck Biotech Development Facility in Switzerland
- Sustainability and Energy Management
- Merck’s Existing Manufacturing Sites in Switzerland
- Marketing Commentary on Merck
- GeneratedCaptionsTabForHeroSec
The facility is situated near the company’s existing biotech commercial manufacturing centre in Corsier-sur-Vevey. It will include a building with a total area of approximately 15,700m² (168,993m²), with operations supported by around 250 employees currently operating in different locations. The cross-functional team will work on expediting the ava...
The facility will incorporate advanced technological and digital solutions. Merck also plans to integrate automationinto manufacturing and laboratory processes. The facility will have flexible design features and open workspaces to allow the team to collaborate and innovate. It will comply with international standards for the environment, health, q...
Sustainable features such as efficient energy management systems and recycling systems will be installed at the centre. The design is intended to allow ample natural light to enter the building. Dynamic liquid crystal windows designed by Merck’s Performance Materials’ eyrise™ brand will be installed in the facility to regulate daylight quality and ...
Merck operates in nine locations across Switzerland, from which it carries out business activities in the healthcare, life sciences and performance materials sectors. The company has five manufacturing sites in the country, including two dedicated to its Healthcare business and three under its Life Science business. The company’s Aubonne and Corsie...
Merck is a multinational pharmaceutical, life sciences and chemicals company. Founded in 1668, the company is based in Darmstadt, Germany, and operates through three business segments, namely Life Sciences, Performance Materials and Healthcare. The company has around 56,000 employees across 66 locations worldwide. Its key therapeutic areas include ...
Merck is building a €250m ($275.5m) biotech development centre in Switzerland, expected to be operational by 2023. The facility will focus on the development and manufacturing of biotech medicines for clinical studies and will feature advanced technological and sustainable solutions.
27. Jan. 2020 · Merck investiert in hochmodernes Biotech-Entwicklungs-Center in der Schweiz. Merck, ein führendes Wissenschafts- und Technologieunternehmen, hat heute bekanntgegeben, dass das Unternehmen 250 Millionen Euro in eine neue Anlage in Corsier-sur-Vevey in der Schweiz investieren wird.
27. Jan. 2020 · Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced an investment of € 250 million in a new facility in Corsier-sur-Vevey, Switzerland – the Biotech Development Center – dedicated to biotech development and manufacturing for clinical studies.
28. Jan. 2020 · Le canton de Vaud salue le début des travaux de construction du nouveau centre de développement Biotech de Merck, à Corsier-sur-Vevey. Le groupe a annoncé un investissement de 270 millions...
6. Juli 2021 · Das Biotech Development Center entsteht in unmittelbarer Nähe zum Produktionsstandort Corsier-sur-Vevey von Merck als Schnittstelle zwischen Forschung und Herstellung.
